Bullish Case: Known: BYRN’s IV is extremely backwardated and skewed, but the helium–market IV gap is mostly not “catastrophe-like” near ATM/low strikes (suggesting market is paying extra for downside). Inferred: if the next 1–6 weeks pass without a fresh regulatory/earnings/distribution shock, mean-reversion + IV compression could lift price. Calibration: recent action looks range-bound vs my earlier crash-tail calls.

Bearish Case: Known: the IV surface shows very high short-dated, low-strike put IV (hundreds %), implying traders price imminent tail risk. Inferred: backwardation concentrates anxiety in the near window; “flat spot + high IV” can flip quickly on an adverse filing/headline. Uncertain: the specific trigger (regulatory, guidance, dilution, funding, distribution) isn’t known—only that the market is already hedging for it.

Potential Outcomes:

1. 45%: 0–15% grind up; falsifiable if next neutral filings leave spot ≥$5.6 and near-term put IV doesn’t keep rising. Oracle: defined-risk call spreads/diagonal calls.
2. 18%: 7–8 breakout; falsifiable by sustained hold >$6.6 for ~2 weeks. Oracle: calls funded by put spread.
3. 22%: 4.5–5 drift; falsifiable if demand/reg-news hits and put IV bids back up. Oracle: put spreads.
4. 8%: <3.5 crash; falsifiable if guidance cut + dilution/funding overhang appears. Oracle: convex downside (cheap tail hedges).
5. 7%: IV spike, spot flat; falsifiable if IV rises while price stays range. Oracle: vega-hedged structures.

June 18, 2026